Key takeaways:
Wegovy (semaglutide) is a once-weekly injection for chronic weight management. It’s approved for adults and adolescents ages 12 and older who meet certain body mass index (BMI) criteria.
Wegovy works by mimicking a natural gut hormone called glucagon-like peptide-1 (GLP). It affects your gut, brain, and other organs to make you feel full, reduce cravings, and decrease your appetite.
You’ll get the most from Wegovy if it’s combined with a healthy diet and regular exercise. And because of how Wegovy works, it’s possible to keep the weight off long term — but usually only as long as you’re taking the medication.
Weight loss can be a frustrating journey, especially if you’ve made numerous attempts to manage your weight without achieving your desired results. And while losing weight isn’t easy or simple, Wegovy (semaglutide) is an option your provider may consider if you’re feeling stuck.
Wegovy is a once-weekly injection for chronic weight management in adults and adolescents ages 12 and older. Compared to weight loss pills, it works in several unique ways to help you lose weight. Wegovy does this by mimicking the effects of GLP-1, a gut hormone involved in blood glucose (sugar) control, appetite regulation, and digestion.
So, how exactly does Wegovy work for weight loss? We cover the four ways Wegovy works on your appetite, cravings, and more below.
One of the ways Wegovy works is by slowing down the rate at which food leaves your stomach — called gastric emptying. This can prolong feelings of fullness after you’ve eaten, so you may not need to eat as often. Eating fewer calories can result in weight loss over time.
However, slowed gastric emptying seems to be more significant during the first few months of taking Wegovy. Research suggests that after about 20 weeks (5 months), Wegovy may be less likely to have this effect on your gut. This is one of the reasons why certain Wegovy side effects from slowed gastric emptying, such as nausea, tend to improve over time.
Wegovy doesn’t just work in your gut. It also affects areas of your brain involved in regulating your appetite and fullness. This can reduce feelings of hunger, make you feel full, and reduce the amount of food intake. Some people taking Wegovy say that it also quiets down “food noise” in their head — described by some as constant thoughts revolving around food.
Wegovy’s effects on the brain can also change your food preferences. For example, you may notice reduced cravings for certain foods such as salty snacks or sweets. Along with its appetite-related effects, this may be due to Wegovy interfering with the pleasure or reward you experience from eating these foods.
During clinical trials, people receiving Wegovy reported better control over their cravings during nearly 2 years of treatment compared to people receiving a placebo (injection without medication). The Wegovy group also reported reduced cravings for savory foods — such as dairy and salty, spicy, or starchy foods — during this time.
If you’ve struggled with food cravings in the past, you may find that this is less of an issue with Wegovy. But for some people, this can mean losing your taste for some of your favorite foods. So, it’s important to find nutrient-packed foods that you like to ensure you’re getting adequate nutrition during treatment.
Your appetite, metabolism, and body weight are influenced by several different hormones in your body. GLP-1, the gut hormone mimicked by Wegovy, is one of them. Ghrelin and leptin are a few other key players.
When you eat fewer calories, levels of these hormones can change. Ghrelin, sometimes called the “hunger hormone,” tends to increase — boosting your appetite and telling your body to store fat. And leptin, which tells you to stop eating, tends to decrease. This is thought to be one of the reasons it’s often difficult to maintain weight loss long term.
Wegovy may potentially counteract some of the hormonal changes that happen during weight loss. This may be one of the reasons many people are able to maintain weight loss from Wegovy over time. However, this effect goes away if you stop taking Wegovy.
Keep in mind: Wegovy works best if you combine it with a healthy diet and regular exercise. Maintaining these lifestyle changes is an important way to keep your body healthy over the long term.
Wegovy is a once-weekly injection for chronic weight management in adults and adolescents ages 12 and older. It works several different ways to help with weight loss. These include decreasing your appetite, reducing cravings and changing food preferences, and making you feel full.
Many people taking Wegovy are able to maintain their weight loss. But this is usually only the case if you continue taking it. Since it’s a long-term commitment, talk to your healthcare provider about whether or not Wegovy is right for you.
Ard, J., et al. (2021). Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Advances in Therapy.
Endocrine Society. (2022). Endocrine-related organs and hormones.
Eren-Yazicioglu, C. Y., et al. (2021). Can GLP-1 be a target for reward system related disorders? A qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol. Frontiers in Behavioral Neuroscience.
Friedrichsen, M., et al. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity, and Metabolism.
Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the step 5 trial. Nature Medicine.
Gorgojo-Martínez, J. J.. et al. (2022). Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: A multidisciplinary expert consensus. Journal of Clinical Medicine.
Iepsen, E. W., et al. (2015). Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. International Journal of Obesity.
Society for Endocrinology. (2021). Ghrelin.
Society for Endocrinology. (2021). Glucagon-like peptide 1.
Sumithran, P., et al. (2011). Long-term persistence of hormonal adaptations to weight loss. The New England Journal of Medicine.
Wharton, S., et al. (2023). Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: step 5. Obesity.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.